BRIEF-Cellectar Biosciences Says Workforce Reduction Expected To Decrease Annual Operating Costs

Reuters12-11

Dec 11 (Reuters) - Cellectar Biosciences CLRB.O:

CELLECTAR BIOSCIENCES INC - WORKFORCE REDUCTION EXPECTED TO DECREASE ANNUAL OPERATING COSTS BY $7.5 MILLION
CELLECTAR BIOSCIENCES INC - ESTIMATES TO INCUR SEVERANCE COSTS OF APPROXIMATELY $1.7 MILLION

Source text: [ID:n0001104659-24-127487]

Further company coverage: CLRB.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2490850272?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-11 22:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490850272","market":"us","top_or_hot":-1,"title":"BRIEF-Cellectar Biosciences Says Workforce Reduction Expected To Decrease Annual Operating Costs","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Cellectar Biosciences Says Workforce Reduction Expected To Decrease Annual Operating Costs </title></head><body><p><span>Dec 11 (Reuters)</span><span> - </span>Cellectar Biosciences <span>CLRB.O</span>:</p><ul><li><p>CELLECTAR BIOSCIENCES INC - WORKFORCE REDUCTION EXPECTED TO DECREASE ANNUAL OPERATING COSTS BY $7.5 MILLION</p></li><li><p>CELLECTAR BIOSCIENCES INC - ESTIMATES TO INCUR SEVERANCE COSTS OF APPROXIMATELY $1.7 MILLION</p></li></ul><p>Source text: [ID:n0001104659-24-127487]</p><p>Further company coverage: <span>CLRB.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Cellectar Biosciences Says Workforce Reduction Expected To Decrease Annual Operating Costs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Cellectar Biosciences Says Workforce Reduction Expected To Decrease Annual Operating Costs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-11 22:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0NP:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Cellectar Biosciences Says Workforce Reduction Expected To Decrease Annual Operating Costs Dec 11 (Reuters) - Cellectar Biosciences CLRB.O:CELLECTAR BIOSCIENCES INC - WORKFORCE REDUCTION ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0NP:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLRB","symbol_name":"Cellectar Biosciences Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0NP:1","article_id":"2490850272","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490850272","pubTimestamp":1733926570,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Cellectar Biosciences Says Workforce Reduction Expected To Decrease Annual Operating Costs Dec 11  - Cellectar Biosciences CLRB.O:CELLECTAR BIOSCIENCES INC - WORKFORCE REDUCTION EXPECTED TO DECREASE ANNUAL OPERATING COSTS BY $7.5 MILLIONCELLECTAR BIOSCIENCES INC - ESTIMATES TO INCUR SEVERANCE COSTS OF APPROXIMATELY $1.7 MILLIONSource text: [ID:n0001104659-24-127487]Further company coverage: CLRB.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CLRB":"Cellectar Biosciences Inc."},"translate_title":"简介-Cellectar Biosciences表示裁员预计将降低年度运营成本","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLRB":0.9},"content_text":"BRIEF-Cellectar Biosciences Says Workforce Reduction Expected To Decrease Annual Operating Costs Dec 11 (Reuters) - Cellectar Biosciences CLRB.O:CELLECTAR BIOSCIENCES INC - WORKFORCE REDUCTION EXPECTED TO DECREASE ANNUAL OPERATING COSTS BY $7.5 MILLIONCELLECTAR BIOSCIENCES INC - ESTIMATES TO INCUR SEVERANCE COSTS OF APPROXIMATELY $1.7 MILLIONSource text: [ID:n0001104659-24-127487]Further company coverage: CLRB.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490850272"}